MDAI · XBRL financial data

Spectral AI financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MDAI's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	—	25,368	18,056	29,581	19,650
Cost of revenue	—	14,531	10,176	16,307	10,725
Gross profit	—	10,837	7,880	13,274	8,925
Research and development	—	16,500	15,100	—	—
General and administrative	3,421	1,251	20,864	19,856	17,528
Total operating expenses	—	736	—	19,856	17,528
Operating income (loss)	(3,421)	(1,251)	(12,984)	(6,582)	(8,603)
Interest income	27	3,156	172	14	—
Interest expense	—	—	—	(14)	886
Income tax expense (benefit)	(1,272)	614	11	271	11
Net income (loss)	(2,148)	11,039	(20,854)	(15,315)	(7,571)
Earnings per share, basic USD per share	—	(0.22)	(1.48)	(0.85)	(0.29)
Earnings per share, diluted USD per share	—	(0.22)	(1.48)	(0.85)	(0.29)
Weighted average shares, basic thousands of shares	—	13,137	14,088	17,934	26,518
Weighted average shares, diluted thousands of shares	—	13,137	14,088	17,934	26,518

Fiscal years (MDAI's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	769	785	4,790	5,200	15,400
Accounts receivable	—	2,294	2,346	2,505	1,267
Inventory	—	—	230	425	838
Total current assets	1,083	939	9,902	10,122	19,453
Property and equipment, net	—	21	12	2	258
Right-of-use asset	—	1,008	778	1,971	1,407
Total assets	254,110	5,565	10,692	12,095	21,405
Accounts payable	—	2,759	2,683	4,035	3,010
Accrued liabilities	2,909	3,352	4,300	3,210	2,341
Total current liabilities	2,937	3,624	12,401	17,644	20,626
Long-term debt	—	—	—	—	5,538
Lease liability, non-current	—	346	—	1,702	968
Total liabilities	21,935	12,873	12,401	19,346	27,132
Accumulated deficit	(20,825)	(12,097)	(32,788)	(48,103)	(55,800)
Total stockholders' equity	(20,825)	(12,096)	(1,709)	(7,251)	(5,727)
Total liabilities and equity	254,110	5,565	10,692	12,095	21,405
Common shares outstanding (cover page) thousands of shares	—	13,170	17,467	25,317	31,824

Fiscal years (MDAI's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(2,148)	11,039	(20,854)	(15,315)	(7,571)
Stock-based compensation	—	1,155	1,243	1,032	1,115
Net cash from operating activities	(826)	(1,019)	(13,240)	(9,199)	(9,920)
Net cash from investing activities	(253,000)	251,557	—	—	—
Proceeds from issuing common stock	13,935	13,935	3,351	4,060	10,638
Share repurchases	0	250,523	—	—	—
Net cash from financing activities	254,595	(250,523)	3,844	9,575	20,120
Net change in cash	769	16	(9,384)	367	10,237

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Spectral AI	14,000	3,524	(4,097)*	32.2M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Sensus Healthcare	15,186	2,290	(3,133)*	16.5M	4.8 quarters	Q2 FY26 10-QJun 30, 2026
CapsoVision	not reported	3,643	(8,403)*	50.0M	—	Q2 FY26 10-QJun 30, 2026
enVVeno Medical	2,585	not reported	(3,178)*	694,826	5.6 quarters	Q3 FY26 10-QSep 30, 2026
Pro Dex	11,759	20,560	6,490	3.2M	—	Q1 FY27 10-QSep 30, 2026
TELA Bio	30,424	19,291	(9,381)*	44.9M	3.2 quarters	Q2 FY26 10-QJun 30, 2026
Apyx Medical	27,617	13,884	(3,490)*	42.1M	7.9 quarters	Q2 FY26 10-QJun 30, 2026
Orchestra BioMed Holdings	20,472	88	(19,332)*	60.1M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Lucid Diagnostics	33,404	not reported	(11,297)*	203.2M	3.0 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.